Purpose
to evaluate the safety and efficacy of the CRISPR-Cas13 system with the goal of enabling a pre-clinical animal study to test this modality in non-human primates
Grantee
Division
Global Health
Date
OCTOBER 2021
Region served
GLOBAL
Committed amount
$1,235,112
Grant topic
Discovery and Translational Sciences
Duration (months)
32
Grantee location
Redwood City, California, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.